Gateway 2011: Corden Pharma - Pharmaceutical Technology

Latest Issue

Latest Issue
PharmTech Europe

Gateway 2011: Corden Pharma

Corden Pharma
68723 Plankstadt, Germany
Phone: +49 6202 99-2299
Fax: +49 6202 99-2000

General Company Company Description:

Corden Pharma is a specialized contract manufacturer utilizing sophisticated technologies developed through years of proven experience that are ideal for the production of oral and sterile highly potent or antibiotic pharmaceutical products and their active ingredients.

We offer customised service packages which span the entire pharmaceutical product continuum from development and manufacturing of Active Pharmaceuticals Ingredients, formulation development, assistance with approval procedures, and commercial production of Drug Products, all the way to complete pharmaceutical logistics.

Our plants, located across Europe and in the US, are audited by all relevant approval authorities, making Corden Pharma a premier partner for pharmaceutical companies worldwide.

Visit Corden Pharma at CPhI booth 31B04 and/or AAPS booth 1524 to discover the services, technologies and products which distinguish Corden Pharma as a Full-Service Development and Contract Manufacturer:

  • Custom API Manufacturing
  • Generic API Manufacturing
  • Drug Product Development and Manufacturing
  • Generic Dossier Development
  • Formulation Capabilities
  • Packaging
  • Clinical Supply Services
  • Specialized Technologies, including High Potent APIs and Peptides
  • Readily Available Excipients, Building Blocks and Generic Bulk APIs

Contact: to arrange meetings for CPhI to arrange meetings for AAPS

PDF/Online Documents

Corden Pharma Switzerland Custom Manufacturing Brochure

Corden Pharma Switzerland Lipids Brochure

Corden Pharma Switzerland Lipids Price List

Corden Pharma Switzerland Pseudoproline Dipeptides Brochure

Corden Pharma Switzerland Pseudoproline Dipeptides Price List

Corden Pharma Switzerland Oligonucleotide-Based Therapeutic Delivery


blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
| Weekly

FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
View Results
Eric Langerr Outsourcing Outlook Eric LangerTargeting Different Off-Shore Destinations
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAsymmetric Synthesis Continues to Advance
Jill Wechsler Regulatory Watch Jill Wechsler Data Integrity Key to GMP Compliance
Sean Milmo European Regulatory WatchSean MilmoExtending the Scope of Pharmacovigilance Comes at a Price
New FDA Team to Spur Modern Drug Manufacturing
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Ebola Outbreak Raises Ethical Issues
Better Comms Means a Fitter Future for Pharma, Part 2: Realizing the Benefits of Unified Communications

Click here